In this program, expert faculty review and discuss real-world applications of the latest, practice-changing data across different therapeutic areas within cardiovascular medicine presented at the American Heart Association Scientific Session 2022.
Analysis from the American Heart Association Scientific Session 2022 – Integrating Complex Data into Clinical Practice
Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients with COVID-19: Primary Results of the PREVENT-HD Randomized Clinical Trial
In this program, expert faculty review and discuss real-world applications of the latest, practice-changing data across different therapeutic areas within cardiovascular medicine presented at the American Heart Association Scientific Session 2022.
This activity has been designed to meet the educational needs of the interprofessional team, including academic and community-based clinical and interventional cardiologist, critical care clinicians, interventional radiologist, emergency/hospital/vascular medicine clinicians, nurses, physician assistants, pharmacists, and other health care professionals involved in the management of patients with cardiovascular disorders.
After participating in this educational activity, participants should be better able to:
In support of improving patient care, this activity has been planned and implemented by Global Learning Collaborative (GLC) and TotalCME, Inc. GLC is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 1.25 Interprofessional Continuing Education (IPCE) credits for learning and change.
In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all educational programs.
The following faculty have disclosed:
Robert J. Mentz, MD, faculty for this educational event, receives research support from Abbott, American Regent, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Boston Scientific, Cytokinetics, Fast BioMedical, Gilead, Innolife, Eli Lilly, Medtronic, Merck, Novartis, Pharmacosmos, Relypsa, Respicardia, Roche, Sanofi, Vifor, Windtree Therapeutics, and Zoll; and receives consulting fees from Abbott, American Regent, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Boston Scientific, Cytokinetics, Fast BioMedical, Gilead, Innolife, Eli Lilly, Medtronic, Merck, Novartis, Pharmacosmos, Relypsa, Respicardia, Roche, Sanofi, Vifor, Windtree, Therapeutics, and Zoll.
Karol E. Watson, MD, PhD, FNLA, FACC, FAHA, faculty for this educational event, research support from NHLBI, NIDDK, BD2K consortium, B2AI consortium; and receives consulting fees from Boehringer-Ingelheim, Amgen, Amarin, AstraZeneca, Boehringer-Ingelheim, Lilly, Novo, Nordisk and Novartis.
Javed Butler, MD, MPH, MBA, faculty for this educational event, receives consulting fees from Abbott, Adrenomed, Amgen, Applied Therapeutics, Array, AstraZeneca, Bayer, Boehringer-Ingelheim, BMS, CVRx, G3 Pharma, Impulse Dynamics, Innolife, Janssen, LivaNova, Lultpold, Medtronic, Merck, Novartis, NovoNordisk, Relypsa, Roche, Sequana Medica and Vifor.
George L. Bakris, MD, faculty for this educational event, receives consulting fees from Bayer, KBP Biosciences, Ionis, Alnylam, Astra Zeneca, Quantum Genomics, Horizon, Novo Nordisk, Dia Medica Therapeutics and InREGEN.
Manesh R. Patel, MD, faculty for this educational event, received research support from Astra Zeneca, Bayer, Janssen, Mytonomy and Procyrion; and receives consulting fees from Bayer, Janssen and Novartis.
Sreekanth Vemulapalli, MD, faculty for this educational event, received research support from American College of Cardiology, Society of Thoracic Surgeons, Cytokinetics, Abbott Vascular, Boston Scientific, National Institutes of Health (SBIR and R01), Food and Drug Administration (NEST cc); and receives consulting fees from Medtronic, Edwards Lifesciences and American College of Physicians.
Gregory Piazza, MD, MS, faculty for this educational event, received research support from BMS, Pfizer, Janssen, Bayer, Alexion, BSC, Esperion and Amgen; and received consulting fees from BMS, Pfizer, BSC, PERC, Namsa and Amgen.
The following planners/reviewers/managers have disclosed:
Prerna Poojary, PhD, planner for this educational event, has no relevant financial relationships with ineligible companies.
William Mencia, MD, FACEHP, CHCP, reviewer for this educational event, has no relevant financial relationships with ineligible companies.
TotalCME, Inc. planners and managers have no relevant commercial relationships to disclose.
All the relevant financial relationships for these individuals have been mitigated.
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and TotalCME, Inc. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of MedEd On The Go you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.
Reproduction Prohibited
Reproduction of this material is not permitted without written permission from the copyright owner.
Supported by educational grants from Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC and Merck Sharp & Dohme LLC.
Jointly provided by Global Learning Collaborative (GLC) and TotalCME, Inc.
This activity is FREE to all participants.
During the period 11/23/22 through 11/23/23, registered participants wishing to receive continuing education credit for this activity must follow these steps:
For Pharmacists: Upon successfully completing the post-test with a score of 100% and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service. This may require you to add or update the e-profile ID/date of birth information saved in your account.
Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.
Release Date:
Expiration Date:
Facebook Comments